PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $196,000 | -11.7% | 38,916 | +9.0% | 0.00% | 0.0% |
| Q2 2019 | $222,000 | +19.4% | 35,709 | -10.4% | 0.00% | 0.0% |
| Q1 2019 | $186,000 | +8.8% | 39,875 | -1.3% | 0.00% | 0.0% |
| Q4 2018 | $171,000 | +30.5% | 40,404 | +92.0% | 0.00% | – |
| Q3 2018 | $131,000 | -23.8% | 21,043 | -2.4% | 0.00% | -100.0% |
| Q2 2018 | $172,000 | -14.9% | 21,557 | -20.3% | 0.00% | 0.0% |
| Q1 2018 | $202,000 | +25.5% | 27,063 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $161,000 | -14.4% | 27,063 | +5.9% | 0.00% | 0.0% |
| Q3 2017 | $188,000 | +8.0% | 25,563 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $174,000 | -27.8% | 25,563 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $241,000 | -30.7% | 25,539 | -36.5% | 0.00% | 0.0% |
| Q4 2016 | $348,000 | +121.7% | 40,250 | +61.3% | 0.00% | 0.0% |
| Q3 2016 | $157,000 | +58.6% | 24,956 | +6.4% | 0.00% | – |
| Q2 2016 | $99,000 | – | 23,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|